EVOQ Therapeutics Overview

  • Year Founded
  • 2016

Year Founded

  • Status
  • Private

  • Employees
  • 10

Employees

  • Latest Deal Type
  • Grant

  • Latest Deal Amount
  • $2M

  • Investors
  • 14

EVOQ Therapeutics General Information

Description

Developer of immunotherapies designed to improve the lives of individuals fighting autoimmune diseases. The company's technology focuses on utilizing a novel, proprietary nanodisc-based therapy that delivers efficacy in multiple pre-clinical models like celiac disease, type one diabetes, lupus, pemphigus, graves, rheumatoid arthritis, and more, enabling doctors to unleash and restore the body's natural immune tolerance pathways.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 1600 Huron Parkway
  • Building 520, 2nd Floor
  • Ann Arbor, MI 48109
  • United States
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Corporate Office
  • 1600 Huron Parkway
  • Building 520, 2nd Floor
  • Ann Arbor, MI 48109
  • United States

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

EVOQ Therapeutics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
9. Grant 01-Aug-2024 $2M Completed Product Development
8. Grant 12-Jul-2022 Completed Product Development
7. Later Stage VC 25-Oct-2021 Completed Product Development
6. Early Stage VC 17-Jan-2020 Completed Product Development
5. Grant 13-Nov-2019 Completed Product Development
4. Seed Round 14-Mar-2018 Completed Product Development
3. Accelerator/Incubator 01-Jan-2017 Completed Product Development
2. Grant $685K Completed Product Development
1. University Spin-Out 01-Jan-2016 Completed Product Development
To view EVOQ Therapeutics’s complete valuation and funding history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

EVOQ Therapeutics Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of immunotherapies designed to improve the lives of individuals fighting autoimmune diseases. The company's te
Drug Discovery
Ann Arbor, MI
10 As of 2025

Seattle, WA
 

Pasadena, CA
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

EVOQ Therapeutics Competitors (70)

One of EVOQ Therapeutics’s 70 competitors is Mozart Therapeutics, a Venture Capital-Backed company based in Seattle, WA.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Mozart Therapeutics Venture Capital-Backed Seattle, WA
Meditope Biosciences Formerly VC-backed Pasadena, CA
Shinobi Therapeutics Venture Capital-Backed South San Francisco, CA
Vedanta Biosciences Venture Capital-Backed Cambridge, MA
Prevail Therapeutics Formerly VC-backed New York, NY
You’re viewing 5 of 70 competitors. Get the full list »

EVOQ Therapeutics Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

EVOQ Therapeutics Investors (14)

Investor Name Investor Type Holding Investor Since Participating Rounds
National Institutes of Health Government
Biosciences Research and Commercialization Center Venture Capital Minority
Transhuman Capital Venture Capital Minority
Invest Michigan Venture Capital Minority
Michigan Founders Fund Not-For-Profit Venture Capital Minority
You’re viewing 5 of 14 investors. Get the full list »

EVOQ Therapeutics FAQs

  • When was EVOQ Therapeutics founded?

    EVOQ Therapeutics was founded in 2016.

  • Where is EVOQ Therapeutics headquartered?

    EVOQ Therapeutics is headquartered in Ann Arbor, MI.

  • What is the size of EVOQ Therapeutics?

    EVOQ Therapeutics has 10 total employees.

  • What industry is EVOQ Therapeutics in?

    EVOQ Therapeutics’s primary industry is Drug Discovery.

  • Is EVOQ Therapeutics a private or public company?

    EVOQ Therapeutics is a Private company.

  • What is EVOQ Therapeutics’s current revenue?

    The current revenue for EVOQ Therapeutics is .

  • How much funding has EVOQ Therapeutics raised over time?

    EVOQ Therapeutics has raised $2.2M.

  • Who are EVOQ Therapeutics’s investors?

    National Institutes of Health, Biosciences Research and Commercialization Center, Transhuman Capital, Invest Michigan, and Michigan Founders Fund are 5 of 14 investors who have invested in EVOQ Therapeutics.

  • Who are EVOQ Therapeutics’s competitors?

    Mozart Therapeutics, Meditope Biosciences, Shinobi Therapeutics, Vedanta Biosciences, and Prevail Therapeutics are some of the 70 competitors of EVOQ Therapeutics.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process